Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a pilot randomized controlled trial to assess the pharmacokinetics and
pharmacodynamics of azithromycin in pregnant singletons admitted with preterm premature
rupture of membranes (PPROM) at 24 0/7- 33 0/7. Participants will be randomized 1:1 to either
1000mg azithromycin orally once or 500mg azithromycin orally daily for seven days in addition
to standard care.